86 related articles for article (PubMed ID: 3055516)
21. 31P magnetic resonance spectroscopy of the isolated human donor liver--feasibility in routine clinical practice and preliminary findings.
Wolf RF; Kamman RL; Mooyaart EL; Haagsma EB; Bleichrodt RP; Slooff MJ
Transplantation; 1993 Apr; 55(4):949-51. PubMed ID: 8475572
[No Abstract] [Full Text] [Related]
22. Measurement of viability in preserved kidneys with 31P NMR.
Kunikata S; Ishii T; Nishioka T; Uemura T; Kanda H; Matsuura T; Akiyama T; Kurita T
Transplant Proc; 1989 Feb; 21(1 Pt 2):1269-71. PubMed ID: 2652420
[No Abstract] [Full Text] [Related]
23. Long-term assessment of posttransplant renal prognosis with 31 P magnetic resonance spectroscopy.
Seto K; Ikehira H; Obata T; Sakamoto K; Yamada K; Kashiwabara H; Yokoyama T; Tanada S
Transplantation; 2001 Aug; 72(4):627-30. PubMed ID: 11544421
[TBL] [Abstract][Full Text] [Related]
24. Importance of pH in renal preservation.
Nghiem DD; Elkadi H; Southard JH
Transplant Proc; 1988 Oct; 20(5):872-4. PubMed ID: 3055521
[No Abstract] [Full Text] [Related]
25. Left ventricular contractility after hypothermic preservation: predictive value of phosphorus 31-nuclear magnetic resonance spectroscopy.
Carteaux JP; Mertes PM; Pinelli G; Escanye JM; Walker P; Brunotte F; Jaboin Y; Robert J; Villemot JP
J Heart Lung Transplant; 1994; 13(4):661-8. PubMed ID: 7947883
[TBL] [Abstract][Full Text] [Related]
26. Viability testing of kidneys for transplantation.
Lannon SG; Bickis I; Dossetor JB
Invest Urol; 1971 Nov; 9(3):180-3. PubMed ID: 4944751
[No Abstract] [Full Text] [Related]
27. Pretransplant evaluation of kidney vasculature by image-guided volume selective 19F NMR spectroscopy.
Pomer S; Hull WE; Kempter F; Kumar A; Staehler G
Transplant Proc; 1991 Oct; 23(5):2404. PubMed ID: 1926404
[No Abstract] [Full Text] [Related]
28. The role of magnetic resonance spectroscopy in the assessment of kidney viability.
Barnard ML; Changani KK; Taylor-Robinson SD
Scand J Urol Nephrol; 1997 Oct; 31(5):487-92. PubMed ID: 9406313
[TBL] [Abstract][Full Text] [Related]
29. Magnetic resonance spectroscopy in focal epilepsy: 31P and 1H spectroscopy.
Kuzniecky R
Rev Neurol (Paris); 1999 Jul; 155(6-7):495-8. PubMed ID: 10472666
[TBL] [Abstract][Full Text] [Related]
30. Proceedings: Renal cortical cation composition as an index of human kidney graft viability.
Sells RA; McLoughlin GA; Tyrrell I
Br J Surg; 1974 Apr; 61(4):326. PubMed ID: 4598986
[No Abstract] [Full Text] [Related]
31. Improved pretransplant assessment of renal quality by means of phosphorus-31 magnetic resonance spectroscopy using chemical shift imaging.
Niekisch MB; Von Elverfeldt D; El Saman A; Hennig J; Kirste G
Transplantation; 2004 Apr; 77(7):1041-5. PubMed ID: 15087769
[TBL] [Abstract][Full Text] [Related]
32. Application of phosphorus nuclear magnetic resonance to problems of renal physiology and metabolism.
Wong GG; Ross BD
Miner Electrolyte Metab; 1983; 9(4-6):282-9. PubMed ID: 6656708
[No Abstract] [Full Text] [Related]
33. Application of machine perfusion preservation as a viability test for marginal kidney graft.
Matsuno N; Konno O; Mejit A; Jyojima Y; Akashi I; Nakamura Y; Iwamoto H; Hama K; Iwahori T; Ashizawa T; Nagao T
Transplantation; 2006 Dec; 82(11):1425-8. PubMed ID: 17164712
[TBL] [Abstract][Full Text] [Related]
34. Relation between pO2, 31P magnetic resonance spectroscopy parameters and treatment outcome in patients with high-grade soft tissue sarcomas treated with thermoradiotherapy.
Dewhirst MW; Poulson JM; Yu D; Sanders L; Lora-Michiels M; Vujaskovic Z; Jones EL; Samulski TV; Powers BE; Brizel DM; Prosnitz LR; Charles HC
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):480-91. PubMed ID: 15667971
[TBL] [Abstract][Full Text] [Related]
35. Assessment of functional activity of cold-stored kidney transplant by proton magnetic resonance spectroscopy.
Hauet T; Mothes D; Goujon JM; Badia P; Carretier M; Caritez JC; Robert R; Tallineau C; Eugene M
Transplant Proc; 1996 Oct; 28(5):2896-8. PubMed ID: 8908115
[No Abstract] [Full Text] [Related]
36. Ischemic injury of the small intestine studied by 31P-MRS.
Sato A; Kataoka M; Kuwabara Y; Kimura M; Seo Y; Masaoka A
J Surg Res; 1996 Mar; 61(2):373-8. PubMed ID: 8656611
[TBL] [Abstract][Full Text] [Related]
37. Developmental changes of phosphorus metabolite concentrations in the human brain: a 31P magnetic resonance spectroscopy study in vivo.
Buchli R; Martin E; Boesiger P; Rumpel H
Pediatr Res; 1994 Apr; 35(4 Pt 1):431-5. PubMed ID: 8047379
[TBL] [Abstract][Full Text] [Related]
38. MR spectroscopy of musculoskeletal soft-tissue tumors.
Negendank WG
Magn Reson Imaging Clin N Am; 1995 Nov; 3(4):713-25. PubMed ID: 8564691
[TBL] [Abstract][Full Text] [Related]
39. Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy.
Muruganandham M; Alfieri AA; Matei C; Chen Y; Sukenick G; Schemainda I; Hasmann M; Saltz LB; Koutcher JA
Clin Cancer Res; 2005 May; 11(9):3503-13. PubMed ID: 15867253
[TBL] [Abstract][Full Text] [Related]
40. [Magnetic resonance spectroscopy in schizophrenia].
Delamillieure P; Constans JM; Fernandez J; Dollfus S
Encephale; 2000; 26(1):21-31. PubMed ID: 10875059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
